LL-37
Typical Dosage
Topical: 1-10%
Injection: 50-125 mcg
Administration
Topical • Injection
Half-Life
~30 minutes (plasma)
Mechanism of Action
Antimicrobial defense research|Wound repair|Biofilm and immune-signaling studies|Inflammation modulation
Research Protocol Summary
Evidence Level
Early Human / Investigational
Typical Protocol Duration
Varies By Research Protocol
Species Studied
Human • Mouse
Administration Schedule
Daily
Studies
Research Availability
Individual PubMed records have not been mapped for this entry yet. Use the linked PubMed search to review the current literature directly.
Related resources
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Loading approved insights…